Strong start to FY26 with ₹875 Cr revenue; USFDA clearance, 20+ audits, and peptide lab expansion underline quality-first strategy Bengaluru, 23 July 2025 , ...
Strong start to FY26 with ₹875 Cr revenue; USFDA clearance, 20+ audits, and peptide lab expansion underline quality-first strategy Bengaluru, 23 July 2025 , ...